Quick Takeaways
- Sio Capital Management, LLC filed SCHEDULE 13G/A for Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE).
- Disclosed ownership: 1.9%.
- Date of event: 30 Sep 2025.
Sio Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE)
- Filing Manager
- Sio Capital Management, LLC
- Reporting Manager
- Sio Capital Management, LLC
- Symbol
- APRE
- Shares outstanding
- 5,814,663 shares
- Disclosed Ownership
- 112,223 shares
- Ownership
- 1.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 08:00:21 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sio Capital Management, LLC disclosed 1.9% ownership in Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 12 Nov 2025, 08:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC | 1.9% | 112,223 | 0 | 112,223 | Jin W. Lee | Chief Compliance Officer |